packageGemigliptin

gemigliptin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Gemigliptin is a DPP-4 inhibitor developed as an oral blood glucose lowering drug for diabetes. It is classed as investigational and is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q5530612 and the WHO ATC classification; not checked by a person.

name:gemigliptin
ATC codes:A10BH06
DrugBank:DB12412
PubChem CID:11953153
ChEBI:134731
Wikidata:Q5530612
formula:C18H19F8N5O2
molar mass:489.367 g/mol (PubChem CID 11953153)
logP:0.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown